Why Invest in the Southeast? In sum, because the region’s dynamic and growing economy produces strong deal flow at reasonable valuations, and has historically produced higher returns for venture investors than other regions of the country.The Southeastern economy...Read More
RESEARCH TRIANGLE PARK, N.C. – Southeast BIO (SEBIO) announced the EARLY/Stage and BIO/Plan company winners selected during its 15th Annual Investor & Partnering Forum, which was concluded November 7.
CHARLOTTESVILLE, VA – ADial Pharmaceuticals announced that it has entered into a strategic partnership with Cato BioVentures. Cato BioVentures will invest up to $1.8 million in ADial, and Cato Research, an affiliate of Cato BioVentures, will serve as the preferred contract research organization for ADial’s clinical trials of AD04.
Innovative drug therapies, advanced medical devices, diagnostics and other cutting-edge healthcare technologies from throughout the Southeast will be showcased November 6-7, during the 2013 Southeast BIO Investor & Partnering Forum at the Jefferson Hotel in Richmond, Virginia.